Healthcare Innovation CSR News

Volunteers Help Scientists Identify 70 Chemical Candidates To Be Tested Against COVID-19

By Juan Hindo
Blog

Working in a highly collaborative and open effort, scientists have identified 70 virtual compounds to be tested for their capability of inhibiting SARS-CoV2, the virus responsible for COVID-19, hopefully leading to new options for treatment.

Black & Veatch, Oncor Consulting Launch Passport™ Certification Program to Enhance Workplace, Commercial Property Safety

Certification effort will leverage Black & Veatch’s COVID-19 services suite as a platform to provide new facility, population health solutions to commercial property, franchise owners and education sites
Press Release

OVERLAND PARK, Kan., December 8, 2020 /3BL Media/ – There’s a need to forge alliances and working groups to mitigate the COVID-19 pandemic’s impact. Oncor Consulting is among those leading the charge, collaborating with Black & Veatch through their health and safety solutions alliance to deliver a holistic approach to managing population health and creating healthy spaces to work and learn.

Education, Reinvention and Common Action Can Right the Wrongs Exposed by COVID-19

by Ellen Jackowski Chief Sustainability and Social Impact Officer, HP
Summary: 
  • 2020 must not be remembered as a lost year—rather as the springboard for urgent action toward positive, lasting change.
  • Global education access, the reinvention of global solutions with local application, and common action to tip the scale are three imperatives for meaningful change.
Blog
  • 2020 must not be remembered as a lost year—rather as the springboard for urgent action toward positive, lasting change.
  • Global education access, the reinvention of global solutions with local application, and common action to tip the scale are three imperatives for meaningful change.

Ecolab Receives First EPA Approval for Biofilm Disinfection in Drains

Press Release

ST. PAUL, Minn., November 19, 2020 /3BL Media/ - Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, is the first to receive EPA product approval for disinfection of biofilms[i] in wastewater drains for its Virasept™ product – an important part of a comprehensive environmental hygiene program designed to help effectively combat bacterial growth in hospitals.

Virasept (EPA Reg. No. 1677-226) is a patented, peracid mixture, ready-to-use cleaner, deodorizer and hospital disinfectant. 

Precision Medicine Diagnostics Are Driving the Need for Flexible Facility Design

Blog

Precision medicine is based on the idea that each of us is different and may not react the same way to a particular treatment.

Herding Health Data to Provide Clearer Medical Guidance

New health-related data is arriving almost daily. Making sense of it all is a huge challenge.
Article

By Huei-Sin Ee

Get ready for a deluge of health data. The market for bedside monitors, remote health trackers, wearable medical apparatus and digital consumer devices is exploding. And that’s not even counting information collected from critical care instruments or paper questionnaires that most patients are still required to fill out prior to an appointment.

A Day in the Race Against COVID-19

HP microfluidics technology is helping speed up the search for effective treatments to combat the novel coronavirus.
Blog

By Sara Harrison

Tetra Tech's Dominick DeRobertis Discusses Emergency Conversion of an Outpatient Rehab Center to a Surge-Capacity Health Care Facility

Rethinking best practices for the design and operation of health care facilities in light of the COVID-19 pandemic
Blog

Dominick DeRobertis joined Tetra Tech’s High Performance Buildings Group in 2000, becoming a senior vice president and director of health care in 2007. He has more than 25 years of experience in a wide variety of project types, including hospitals, educational facilities, museums, office buildings, hotels, residential buildings, tenant interiors, and retail.

Putting Purpose into Action: Adding Value to Society

What if healthcare innovations could heal beyond the hospital and change communities?
Article

In fiscal year 2020 (FY20), we were powered by our purpose—proving that an enduring Mission can inspire new thinking and innovative ways to alleviate pain, restore health, and extend lives.

In the last year, we invested $2.3 billion in research and development and ran more than 270 clinical studies to engineer and test meaningful innovations that will make a difference to patients and healthcare systems globally. Our investment fuels a product pipeline that impacts more than two patients every second.

Facing Pandemics and Emerging Threats, ATMP Industry Arrives at Intersection of Obstacle and Opportunity

CRB report explores challenges and solutions as cell and gene therapy organizations confront new urgency for patient therapies
Press Release

KANSAS CITY, Mo., Oct. 28, 2020 /3BL Media/ – From the global COVID-19 pandemic to rare and challenging health threats, our world seems forever on the defense against disease and in need of a nimble and efficient vaccine and therapy supply chain. But a new report from CRB, a leading global provider of biopharma manufacturing solutions, spotlights the critical conflicts threatening the speedy delivery of patient therapies.

Pages

Subscribe to Healthcare Innovation